Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis BullosaGlobeNewsWire • 03/17/20
Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™GlobeNewsWire • 02/12/20
Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis BullosaGlobeNewsWire • 01/13/20
Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 12/24/19
Are Options Traders Betting On A Big Move In Abeona Therapeutics (ABEO) Stock?Zacks Investment Research • 12/20/19
Abeona Announces Pricing of Public Offering of Common Stock and Pre‑Funded WarrantsGlobeNewsWire • 12/20/19
Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIAGlobeNewsWire • 12/20/19
Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded WarrantsGlobeNewsWire • 12/19/19
Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis BullosaGlobeNewsWire • 12/09/19
Abeona Therapeutics Announces Presentations at the 27th European Society of Gene and Cell Therapy (ESGCT) CongressGlobeNewsWire • 10/21/19
Abeona Therapeutics Announces Publication of Positive Long-Term Data from Phase 1/2a Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis BullosaGlobeNewsWire • 10/15/19
Cash-Strapped Abeona's Stock Skyrockets As Gene Therapy Company Explores Strategic OptionsBenzinga • 09/03/19
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/12/19
Abeona Therapeutics (ABEO) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/09/19
Analysts Estimate Abeona Therapeutics (ABEO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/01/19
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents DataZacks Investment Research • 06/19/19
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/14/19